Science Explorer Back to mapMap
Discussion
Company · Ústí nad Labem · Czechia

ImunomedicA (Czechia)

imunomedica.czROR OpenAlex
Research works
1
▲ 32% vs 2018-21
Citations
75
54.7 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
24%
world 40%
International
57%
world 18%
ImunomedicA (Czechia)

Not ranked overall: ImunomedicA (Czechia) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does ImunomedicA (Czechia) work in?

In all years, 46% of research at ImunomedicA (Czechia) is in Life Sciences, 46% in Health Sciences. Its largest fields are Immunology and Microbiology (46%), Medicine (38%), Health Professions (8%).

Life Sciences: 1 fractional works · 46.2% of its workImmunology and Microbiology: 1 fractional works · 46.2% of its workHealth Sciences: 1 fractional works · 46.2% of its workMedicine: 0 fractional works · 38.5% of its workHealth Professions: 0 fractional works · 7.7% of its workSocial Sciences: 0 fractional works · 7.7% of its workPsychology: 0 fractional works · 7.7% of its workALL ITS WORKImunomedicA(Czechia)1fractional works, all years
Life Sciences46%Health Sciences46%Social Sciences8%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 4 fields, with their numbers
    1. Immunology and Microbiology146.2%
    1. Medicine038.5%
    2. Health Professions07.7%
    1. Psychology07.7%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from ImunomedicA (Czechia)?

The most cited paper from ImunomedicA (Czechia) is "The role of G-CSF and IL-6 in the granulopoiesis-stimulating activity of murine blood serum induced by perorally administered ultrafiltered pig leukocyte extract, IMUNOR®" (Antonı́n Vacek, Michal Hofer, Jiřina Hòlá et al., 2007), with 9 citations. Next come "Ultrafiltered Pig Leukocyte Extract (UPLE, IMUNOR®) Potentiates Hematopoiesis–Stimulating Effects of G-CSFIn Vitroand Improves the Outcome of Treatment of Hematopoietic Radiation Damage in Mice with G-CSF" (8) and "Physicochemical Characterization of the Oral Biotherapeutic Drug IMUNOR®" (0).

Most cited papers
#PaperReleasedCitations
1 The role of G-CSF and IL-6 in the granulopoiesis-stimulating activity of murine blood serum induced by perorally administered ultrafiltered pig leukocyte extract, IMUNOR® Antonı́n Vacek, Michal Hofer, Jiřina Hòlá et al. · International Immunopharmacology 16 Feb 2007 9
2 Ultrafiltered Pig Leukocyte Extract (UPLE, IMUNOR®) Potentiates Hematopoiesis–Stimulating Effects of G-CSFIn Vitroand Improves the Outcome of Treatment of Hematopoietic Radiation Damage in Mice with G-CSF A Vácek, Milan Höfer, Helena Schneiderová et al. · Immunopharmacology and Immunotoxicology 2005 8
3 Physicochemical Characterization of the Oral Biotherapeutic Drug IMUNOR® Jitka Mucksová, Gabriela Borošová, Miloš Blazsek et al. · Pharmaceuticals Open access 23 Aug 2024 0
All 3 most cited papers, with filters and sorting

Which research topics does ImunomedicA (Czechia) publish most on?

By volume in 2022-now: Immunodeficiency and Autoimmune Disorders, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.

Immunodeficiency and Aut…0Immunodeficiency and Autoimmune Disorders: 0 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksImmunotherapy and Immune…0Immunotherapy and Immune Responses: 0 fractional works
ImmunologyRadiology, Nuclear Medicine and Imaging

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  2. 2 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  3. 3 Immunotherapy and Immune Responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available24.4%not open75.6%

World: 40% of research is openly available.

with international co-authors57.3%domestic only42.7%

World: 18% is written across borders.

How has ImunomedicA (Czechia)'s research output changed?

Output in 2022-2025 was 32% higher than in 2018-2021.

201020152020

Other research institutions in Ústí nad Labem

All research institutions in Ústí nad Labem

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about ImunomedicA (Czechia). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.